3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Dermatologic
1
Conditions
Melanoma
794
Carcinoma, Non-Small-Cell Lung
171
Skin Neoplasms
155
Neoplasms
107
Neoplasm Metastasis
100
Colorectal Neoplasms
97
Carcinoma, Renal Cell
96
Uveal Melanoma
92
Breast Neoplasms
89
Carcinoma, Basal Cell
86
Squamous Cell Carcinoma of Head and Neck
85
Lung Neoplasms
81
Ovarian Neoplasms
79
Sarcoma
67
Lymphoma, T-Cell, Cutaneous
67
Carcinoma, Merkel Cell
67
Pancreatic Neoplasms
59
Stomach Neoplasms
58
Head and Neck Neoplasms
56
Carcinoma, Hepatocellular
54
Uterine Cervical Neoplasms
53
Urinary Bladder Neoplasms
50
Triple Negative Breast Neoplasms
44
Esophageal Neoplasms
44
Prostatic Neoplasms
43
Endometrial Neoplasms
42
Carcinoma, Squamous Cell
40
Brain Neoplasms
39
Carcinoma, Transitional Cell
38
Lymphoma
35
Interventions
vedolizumab
1
Photopheresis
1
Mycophenolic Acid
1
Methoxsalen
1
Infliximab
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hepatitis
×
Dermatologic
×
1 year
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled